Cellectis Sa Stock Analysis

Cellectis Stock Analysis Notes

About 21.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.16. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cellectis SA recorded a loss per share of 1.16. The entity had not issued any dividends in recent years. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France. Cellectis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 294 people. For more info on Cellectis SA please contact Andre Choulika at 33 1 81 69 16 00 or go to https://www.cellectis.com.

Cellectis SA Investment Alerts

Cellectis SA Upcoming and Recent Events

Cellectis Thematic Classifications

Cellectis Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 157.85 M.

Cellectis Profitablity

The company has Profit Margin (PM) of (2.34) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.6) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.6.

Technical Drivers

As of the 26th of February, Cellectis shows the Risk Adjusted Performance of (0.05), mean deviation of 3.63, and Standard Deviation of 6.34. Cellectis SA technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cellectis SA standard deviation and value at risk to decide if Cellectis SA is priced correctly, providing market reflects its regular price of 1.39 per share. Given that Cellectis is a hitting penny stock territory we recommend to closely look at its jensen alpha.

Cellectis SA Price Movement Analysis

Cellectis Outstanding Bonds

Cellectis Predictive Daily Indicators

Cellectis Forecast Models

Cellectis' time-series forecasting models are one of many Cellectis' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cellectis' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cellectis prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cellectis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cellectis. By using and applying Cellectis Stock analysis, traders can create a robust methodology for identifying Cellectis entry and exit points for their positions.

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.